Characteristics and clinical potential of a cellularly modified gelatin sponge

• Published in: Journal of applied biomaterials & functional materials Vol. 19; p. 22808000211035061
• Main Authors: Ye, Danyan, Wu, Sixun, Zhang, Bingna, Hong, Chuzhu, Yang, Lujun
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 2021; Sage Publications Ltd; SAGE Publishing
• Subjects: Animals; Collagen; Gelatin; Growth factors; Histology; Hyaluronic Acid; Immunoassays; Implantation; Lysine; Mesenchymal stem cells; Mesenchyme; Mice; Poly-L-lysine; Sponges; Stem cell transplantation; Stem cells; Ultrastructure; Umbilical cord; Wound Healing; gelatin sponge; 3D culture; scaffold; Mesenchymal stem cells
• ISSN: 2280-8000; 2280-8000
• DOI: 10.1177/22808000211035061

Background:
Human umbilical cord mesenchymal stem cells (HuMSCs) injected directly have been proven effective for improving chronic wounds. However, HuMSCs largely die within 14 days. The aim of study is to establish a cellularly modified gelatin sponge and investigate its characteristics and clinical potential.
Methods:
HuMSCs were isolated, expanded and seeded in a poly-L-lysine (PLL)-coated gelatin sponge. Fabricated gelatin sponges were estimated through observation of morphological surface and ultrastructure, following confirmed by histology method. Supernatants were collected at different times for enzyme-linked immunosorbent assays (ELISAs) to measure growth factors. The cell embedded gelatin sponges were implanted subcutaneously on the backs of mice and the samples were harvested and studied histologically.
Results:
HuMSCs gradually modified the gelatin sponge by depositing collagen and hyaluronic acid, and degrading the structure of gelatin, resulting in a dense, and elastic structure. Compared with cells cultured in monolayer, the levels of growth factors increased remarkably when HuMSCs were cultivated in the gelatin sponge. Upon subcutaneous implantation in the backs of mice, the cellularized gelatin sponges persisted for up to 2 months and eventually integrated into the host tissue, while blank gelatin sponges degraded completely by the end of the second month.
Conclusion:
Gelatin sponge is a clinically accessible scaffold for HuMSCs implantation to maintain short-term survival of the cells and high-level production of growth factors, which demonstrates good clinical potential for enhancing wound healing.